Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-8-27
pubmed:abstractText
Recently, several members of the claudin family have been identified as integral constituents of tight junctions. Using expression profiling, we previously found claudin-4 to be overexpressed in pancreatic cancer. Because claudin-4 has been described as a receptor for the cytotoxic Clostridium perfringens enterotoxin (CPE), we investigated the effect of CPE on pancreatic cancer cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0016-5085
pubmed:author
pubmed:issnType
Print
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
678-84
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11522752-Adenocarcinoma, pubmed-meshheading:11522752-Animals, pubmed-meshheading:11522752-Carcinoma, Pancreatic Ductal, pubmed-meshheading:11522752-Dose-Response Relationship, Drug, pubmed-meshheading:11522752-Enterotoxins, pubmed-meshheading:11522752-Gene Expression Regulation, Neoplastic, pubmed-meshheading:11522752-Humans, pubmed-meshheading:11522752-Membrane Proteins, pubmed-meshheading:11522752-Mice, pubmed-meshheading:11522752-Mice, Nude, pubmed-meshheading:11522752-Neoplasm Transplantation, pubmed-meshheading:11522752-Pancreatic Neoplasms, pubmed-meshheading:11522752-RNA, Messenger, pubmed-meshheading:11522752-Tight Junctions, pubmed-meshheading:11522752-Transforming Growth Factor beta, pubmed-meshheading:11522752-Transplantation, Heterologous, pubmed-meshheading:11522752-Tumor Cells, Cultured
pubmed:year
2001
pubmed:articleTitle
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.
pubmed:affiliation
Department of Internal Medicine I, University Medical Center, University of Ulm, Ulm, Germany.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't